India Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

The India Diabetes Devices Market size is estimated at USD 2.20 billion in 2024, and is expected to reach USD 2.46 billion by 2029, growing at a CAGR of 2.28% during the forecast period (2024-2029).

According to the Article Published in 'THE HINDU' One in six people with diabetes in the world is from India. The numbers place the country among the top 10 countries for people with diabetes, coming in at number two with an estimated 80 million diabetics. Over half of the population in India is at risk of having diabetes at some time in their life, making the disease a significant public health problem. A rise in type 2 diabetes incidence is also being seen in India's rural areas.

High blood sugar levels are a hallmark of the metabolic disorder diabetes mellitus, also known as diabetes. Type 1 diabetes or insulin-dependent diabetes mellitus is caused by a complete lack of insulin. Type 2 diabetes mellitus is a condition where the body does not produce enough insulin, or the body cannot utilize the insulin it produces. Type 2 diabetes is said to be a lifestyle disease. The consumption of sugary sweets is a staple of Indian culture and an integral part of ancient traditions and religious festivals.

Diabetes care devices are devices used to monitor the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. Continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations. India holds the second-largest market in the diabetes care devices market after China in the Asia-Pacific region, because of the increasing diabetes population in the country. The diabetes population in India is expected to reach 92 million by 2027.

Thus, owing to the above factors it is expected to drive the market growth over the forecast period.

India Diabetes Devices Market Trends

Increasing use of monitoring devices in India

In India, the monitoring devices segment is expected to increase with a CAGR of over 7% during the forecast period, mainly due to the demand from the Type-1 diabetes population, which was more than 9 million by the end of the forecast period.

Monitoring devices include self-monitoring blood glucose (SMBG) and continuous glucose monitoring devices (CGM). The SMBG segment held a major share of the Indian diabetes devices market and generated revenue of USD 130.53 million in the current year. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. The awareness of self-monitoring of glucose levels has increased widely in India, and the market for monitoring devices is expected to register high growth in the country with a CAGR of 10% during the forecast period. Type-1 diabetic patients need to check their blood glucose levels at regular intervals to adjust their insulin dosing accordingly. The current CGM devices reduce finger pricking for measuring blood glucose levels. It shows a more detailed representation of blood glucose patterns and tendencies than can be achieved by conventional routine checking of glucose levels at set intervals.

Thus, owing to the above factors, it is expected to drive market growth over the forecast period.

India recorded the second-highest diabetes population in Asia-Pacific

In India, there are currently 80.52 million people suffering from diabetes, and by 2027, nearly 10% of India's population is likely to be affected by diabetes. Obesity, especially central obesity, increased visceral fat due to physical inactivity, and consumption of high-calorie, high-fat, and high-sugar diets are the major contributing factors to diabetes in Indians. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.

In India, the International Diabetes Federation (IDF) estimates that 10% of global health expenditure is spent on diabetes. According to the Ministry of Health and Family Welfare of the Government of India, out of all deaths in India, 60% are related to non-communicable diseases (NCDs). Non-communicable diseases like diabetes, cardiovascular diseases, cancer, chronic respiratory diseases, etc. In order to prevent and control major NCDs, the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) includes medical education, health awareness in schools, and urban planning for diabetes.

Thus, owing to the above factors, it is expected to drive market growth over the forecast period.

India Diabetes Devices Industry Overview

The Indian diabetes care device market is dominated by a few major players. In the CGM market in India, there are only a few players that occupy a major share of the market. However, in the SMBG market, the number of players is high and includes several local players.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.